Medical Devices

Image

Middle East and Africa Exosome Research Products Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Published Report
  • Feb 2023
  • MEA
  • 350 Pages
  • No of Tables: 187
  • No of Figures: 39

Middle East and Africa Exosome Research Products Market, By Product (Instruments and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnostics), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, and Direct Tender) Industry Trends and Forecast to 2030

Middle East and Africa Exosome Research Products Market

Middle East and Africa Exosome Research Products Market Analysis and Insights

Increasing prevalence and incidences of cancer and various autoimmune diseases have enhanced the market demand. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in investments in pharmaceutical R&D and life sciences research also contributes to the rising demand for exosome research product testing.

Middle East and Africa Exosome Research Products Market

Middle East and Africa Exosome Research Products Market

The Middle East and Africa exosome research products market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in R&D activity for launching novel services in the market.

However, the lack of gold standard protocols for developing and producing exosomes might hamper the growth of the Middle East and Africa exosome research products market in the forecast period.

Increasing advancements in exosome technologies are expected to create opportunities for the market to enhance the treatment.

However, the side effects associated with exosome research products and late approval associated with product launches may challenge market growth.

Data Bridge Market Research analyzes that the Middle East and Africa exosome research products market is expected to reach the value of USD 92,348.08 thousand by 2030, at a CAGR of 29.5% during the forecast period. Product accounts for the largest type segment in the market due to the growing use of exosome research products in diagnostics and therapeutics.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Thousand, Volumes in Units, Pricing in USD

Segments Covered

By Product (Instruments and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnostics), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, and Direct Tender)

Countries Covered

South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa

Market Players Covered

Some of the key players operating in the Middle East and Africa Exosome Research Products Market are Hologic Inc., Luminex Corporation, Agilent Technologies, Inc., QIAGEN, FUJIFILM Irvine Scientific( a subsidiary of FUJIFILM Holdings Corporation), CUSABIO TECHNOLOGY LLC, NEXOSOME-ONCOLOGY, Norgen Biotek Corp., Miltenyi Biotec, Beckman Coulter, Inc., and Hitachi, Ltd., among others

Middle East and Africa Exosome Research Products Market Definition

The exosomes are a specific class of cell-derived extracellular vesicles composed of endosomes and are typically 30-150 nm in diameter – the smallest type of extracellular vesicle. Protected by a lipid bilayer, the exosomes are pushed into the extracellular environment, containing a complex cargo derived from the original cell. The contents present in the cargo are proteins, lipids, messenger ribonucleic acid (mRNA), microsomal ribonucleic acid (miRNA), and deoxyribonucleic acid (DNA).

The exosomes have been connected to treat various chronic conditions such as auto-immune disorders. Exosome therapeutics have been widely used in drug delivery, tumor immunotherapy, and diagnostic biomarkers. Exosomes are used as drug carriers due to their small size, native nature, and ability to cross biological barriers.

Middle East and Africa Exosome Research Products Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

  • Growth in the prevalence of cancer, chronic inflammation, auto-immune disease, Lyme disease, and other chronic degenerative diseases

According to WHO, cancer is a top cause of death globally, accounting for approximately 10 million deaths in 2020. The number of cancer patients in India among males was around 679,421, and for females was almost 712,758 for the year 2020. The number of new cancer cases and deaths in 2021 was around 1.9 million, and 608,570 cancer deaths in the United States. Thus, cancer incidence is encouraging researchers to do more and more research, and biomarker is helpful in ide006Etifying cancer. Thus, the market growth is increased.

Thus, in conclusion, the rise in the number of chronic diseases such as cardiovascular diseases, neurological disorders, and various other chronic diseases has led to increased demand for various medicinal drugs and will drive the growth of the Middle East and Africa exosome research products market in the coming years.

  • Increase in investments in pharmaceutical R&D and life sciences research

Academic and research institutes, pharmaceutical and biotechnology businesses, hospitals, and clinical testing laboratories are the major end users of the market. There has been a rise in demand for exosome studies in recent years due to their potential in illness detection and their emerging role as intercellular messengers. This has attracted the interest of several academic researchers, leading to the market's growth. More than 6,000 items are currently being examined in clinical trials worldwide, representing a 68% increase over 2016, per the Pharmaceutical R&D spending trends in 2022.

As the market players are constantly engaged in research and developmental activities, more hybrid and natural exosomes are being introduced in the Middle East and Africa exosome research products market. This would increase the demand for exosome therapeutics to treat cancer and auto-immune diseases in hospitals and diagnostic centers. Hence, the advancements in research and development activities and increasing investments in the pharmaceutical sector are expected to drive overall market growth.

Restraint

  • Lack of gold standard protocols for the development and production of exosomes                                              

The field of exosomes is still at a nascent stage, and no gold standards have been developed so far. Thus the professionals employ new procedures and methodologies in the market without hesitation. In addition to researchers making mistakes during exosome production, scientists face various challenges in exosome research and development and manufacturing activities.

The lack of authentication and safety of the exosomes would hinder the safety protocols and the production of natural and hybrid exosomes. Hence, the lack of standard protocols in developing exosomes and the absence of authentication requirements for the isolation of exosomes are expected to restrain the growth of the exosome research products market.

Opportunity

  • Rise in demand for specialized testing services among end users

Exosomes are small (30–150 nm) vesicles containing sophisticated RNA and protein cargo that are constantly secreted by all cells in vitro and in vivo. Exosomes are changing research due to the intriguing functions within the human body, including intercellular communication and signaling.

Henceforth, the rising use of specialized testing services such as liquid chromatography-mass spectrometry, RNA sequencing, wet chemistry, gene expressions, and various other testing services act as a driver for the growth of the exosome research product market and the ability of these testing services to provide accurate results with precision which has increased the demand among end users.

Challenge

  • Side effects associated with exosome research products

While all medical treatments have benefits and risks, unapproved exosome products expose patients to potential risks without a clear benefit. These products may potentially treat many medical conditions and diseases, but further research is needed to know whether the products have any benefit or are safe to use. The side effects may include injection site reaction, failure of the cells to work as expected, growth of tumors, infections, and the potential for contamination of the product, the ability of cells to move from placement sites and multiply or change into inappropriate cell types

Henceforth, the various side effects of exosome research products for their diagnosis safety, cost, and convenience issues are expected to challenge the Middle East and Africa exosome research products market.

Recent Developments

  • In July 2022, Aethlon Medical, Inc., a medical therapy company focused on developing products for the diagnosis and treatment of cancer and life-threatening infectious diseases, announced that the US Food and Drug Administration (FDA) had approved a protocol amendment for an  ongoing clinical trial of Aethlon Hemopurifier for patients with severe COVID-19
  • In April 2020, ExoDX launched the ExoDx Prostate Test Home Collection Kit for patients concerned about prostate health. The home collection kit provides an immediate and cost-effective solution that enables a telemedicine/telehealth option for physicians and their patients who share the frustration, anxiety, and fear of the advanced prostate cancer patient

Middle East and Africa Exosome Research Products Market Scope

Middle East and Africa exosome research products market is segmented into five notable segments such as product, indication, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT

  • INSTRUMENTS
  • Consumables

On the basis of product, the Middle East and Africa exosome research products market is segmented into instruments and consumables.

MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION

  • CANCER
  • NON CANCER

On the basis of indication, the Middle East and Africa exosome research products market is segmented into cancer and non-cancer.

MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION

  • THERAPEUTICS
  • DIAGNOSTICS

On the basis of application, the Middle East and Africa exosome research products market is segmented into therapeutics and diagnostics.

MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USERS

  •  
  • HOSPITALS
  • CLINICAL TESTING LABORATORIES
  • RESEARCH CENTERS
  • PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
  • ACADEMIC INSTITUTES
  • OTHERS

On the basis of end users, the Middle East and Africa exosome research products market is segmented into hospitals, clinical testing laboratory, research centers, pharmaceutical and biotechnology company, academic institutes, and others.

MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL

  • THIRD PARTY DISTRIBUTORS
  • ONLINE
  • DIRECT TENDER

On the basis of distribution channel, the Middle East and Africa exosome research products market is segmented into third party distributors, online, and direct tender.

Middle East and Africa Exosome Research Products Market Regional Analysis/Insights

The Middle East and Africa exosome research products market is categorized into five notable segments such as product, indication, application, end user, and distribution channel.

The countries covered in this market report are South Africa, Saudi Arabia, U.A.E, Egypt, Israel, and the rest of the Middle East and Africa.

South Africa is expected to dominate in Middle East and Africa region due to technological advancement in exosome research products.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the market's current and future trends. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands, the challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa Exosome Research Products Market Share Analysis

Middle East and Africa exosome research products market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and technology lifeline curve. The above data points are only related to the company's focus on the market of Middle East and Africa exosome research products.

Some of the major players operating in the Middle East and Africa exosome research products market are Hologic Inc., Luminex Corporation, Agilent Technologies, Inc., QIAGEN, FUJIFILM Irvine Scientific ( a subsidiary of FUJIFILM Holdings Corporation), CUSABIO TECHNOLOGY LLC, NEXOSOME-ONCOLOGY, Norgen Biotek Corp., Miltenyi Biotec, Beckman Coulter, Inc., and Hitachi, Ltd., among others.


SKU-

TABLE 1 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS

TABLE 2 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND)

TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 4 MIDDLE EAST & AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 5 MIDDLE EAST & AFRICA KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 6 MIDDLE EAST & AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 7 MIDDLE EAST & AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 8 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 9 MIDDLE EAST & AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 10 MIDDLE EAST & AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 11 MIDDLE EAST & AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 12 MIDDLE EAST & AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 13 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 14 MIDDLE EAST & AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 15 MIDDLE EAST & AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 16 MIDDLE EAST & AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 17 MIDDLE EAST & AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 18 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 20 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)

TABLE 21 MIDDLE EAST & AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 22 MIDDLE EAST & AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)

TABLE 23 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 24 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)

TABLE 25 MIDDLE EAST & AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 26 MIDDLE EAST & AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 27 MIDDLE EAST & AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 28 MIDDLE EAST & AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)

TABLE 29 MIDDLE EAST & AFRICA OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 30 MIDDLE EAST & AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 31 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 32 MIDDLE EAST & AFRICA DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 33 MIDDLE EAST & AFRICA ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 34 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 35 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 36 MIDDLE EAST AND AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 37 MIDDLE EAST AND AFRICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 38 MIDDLE EAST AND AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 39 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 40 MIDDLE EAST AND AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 41 MIDDLE EAST AND AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 42 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 43 MIDDLE EAST AND AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 44 MIDDLE EAST AND AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 45 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 46 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 47 MIDDLE EAST AND AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 48 MIDDLE EAST AND AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 49 MIDDLE EAST AND AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 50 MIDDLE EAST AND AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 51 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 52 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 53 SOUTH AFRICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 54 SOUTH AFRICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 55 SOUTH AFRICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 56 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 57 SOUTH AFRICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 58 SOUTH AFRICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 59 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 60 SOUTH AFRICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 61 SOUTH AFRICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 62 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 63 SOUTH AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 64 SOUTH AFRICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 65 SOUTH AFRICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 66 SOUTH AFRICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 67 SOUTH AFRICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 68 SOUTH AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 69 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 70 EGYPT CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 71 EGYPT KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 72 EGYPT INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 73 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 74 EGYPT CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 75 EGYPT NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 76 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 77 EGYPT THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 78 EGYPT DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 79 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 80 EGYPT PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 81 EGYPT RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 82 EGYPT ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 83 EGYPT CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 84 EGYPT HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 85 EGYPT EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 86 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 87 SAUDI ARABIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 88 SAUDI ARABIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 89 SAUDI ARABIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 90 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 91 SAUDI ARABIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 92 SAUDI ARABIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 93 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 94 SAUDI ARABIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 95 SAUDI ARABIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 96 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 97 SAUDI ARABIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 98 SAUDI ARABIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 99 SAUDI ARABIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 100 SAUDI ARABIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 101 SAUDI ARABIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 102 SAUDI ARABIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 103 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 104 U.A.E. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 105 U.A.E. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 106 U.A.E. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 107 U.A.E. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 108 U.A.E. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 109 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 110 U.A.E. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 111 U.A.E. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 112 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 113 U.A.E. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 114 U.A.E. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 115 U.A.E. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 116 U.A.E. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 117 U.A.E. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 118 U.A.E. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 119 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 120 BAHRAIN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 121 BAHRAIN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 122 BAHRAIN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 123 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 124 BAHRAIN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 125 BAHRAIN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 126 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 127 BAHRAIN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 128 BAHRAIN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 129 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 130 BAHRAIN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 131 BAHRAIN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 132 BAHRAIN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 133 BAHRAIN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 134 BAHRAIN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 135 BAHRAIN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 136 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 137 KUWAIT CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 138 KUWAIT KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 139 KUWAIT INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 140 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 141 KUWAIT CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 142 KUWAIT NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 143 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 144 KUWAIT THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 145 KUWAIT DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 146 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 147 KUWAIT PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 148 KUWAIT RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 149 KUWAIT ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 150 KUWAIT CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 151 KUWAIT HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 152 KUWAIT EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 153 OMAN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 154 OMAN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 155 OMAN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 156 OMAN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 157 OMAN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 158 OMAN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 159 OMAN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 160 OMAN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 161 OMAN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 162 OMAN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 163 OMAN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 164 OMAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 165 OMAN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 166 OMAN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 167 OMAN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 168 OMAN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 169 OMAN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 170 QATAR EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 171 QATAR CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 172 QATAR KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 173 QATAR INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 174 QATAR EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 175 QATAR CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 176 QATAR NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)

TABLE 177 QATAR EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 178 QATAR THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 179 QATAR DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 180 QATAR EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 181 QATAR PHARMACEUTICAL & BIOTECHNOLOGY COMPANY  IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 182 QATAR RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 183 QATAR ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 184 QATAR CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 185 QATAR HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 186 QATAR EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 187 REST OF MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Middle East and Africa Exosome Research Products Market will expand by 29.5% CAGR from 2023 to 2030.
The Middle East and Africa Exosome Research Products Market will be valued at $92,348.08 thousand by 2030.
South Africa is expected to dominate in Middle East and Africa region due to technological advancement in exosome research products.
The countries covered in the report are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials